Indivior PLC (INDV.L)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Indivior Says Filed NDS With Health Canada's For Sublocade Injection
- BRIEF-Indivior Says Filed New Drug Submission With Health Canada For Sublocade Injection
- BRIEF-Indivior files lawsuits over Suboxone patent
- BRIEF-Indivior Says Enters Into License Agreement For C4x Discovery's OX1 Antagonist Program
- UPDATE 1-Rising trade tensions sends FTSE 100 lower